Episurf Medical seeks shareholder approval for IBI bond tender deal, incl. SEK 20 million cash settlement

• Episurf shareholders vote Nov. 12, 2026 on a related-party transaction tied to Ilija Batljan Invest’s tender offer for its Bonds (ISIN SE0016101810).
• Plan calls for a subsidiary to tender SEK 332.5 million nominal Bonds for cash at 100% of nominal plus accrued interest.
• Structure includes set-off against a SEK 350 million promissory note claim, leaving SEK 20 million to be paid in cash to Episurf.
• Board backs the deal as in shareholders’ interest, citing a fairness opinion from MLT Corporate Finance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Episurf Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 202610120120BITN____UKPR__EN_20261012-BIT-1775-0) on October 12, 2026, and is solely responsible for the information contained therein.